Aims To evaluate the value of 18 F-fluoro-2-deoxyglucose positron emission tomography (
18 F-FDG PET) in detecting cardiac sarcoidosis. Methods and results Thirty-two patients with …

Purpose Despite accumulating reports on the clinical value of 18 F-fluoro-2-deoxyglucose
positron emission tomography ( 18 F-FDG PET) and magnetic resonance imaging (MRI) in the …

Background— Balloon pulmonary angioplasty (BPA) is an alternative therapy for patients
with chronic thromboembolic pulmonary hypertension who are ineligible for pulmonary …

BACKGROUND: The accuracy of echocardiographic parameters of right ventricular (RV)
function has not been sufficiently validated in patients with pulmonary hypertension (PH). The …

Background Amino acids (AAs) are emerging as a new class of effective molecules in the
etiology of obesity and diabetes mellitus. However, most investigations have focused on …

Pulmonary hypertension remained an unexplained intractable disease with poor prognosis.
In the last 2 decades, however, the diagnosis and treatment methods for this disease …

Background 18 F-fluorodeoxyglucose (FDG) PET plays an important role in the detection of
cardiac involvement sarcoidosis (CS). However, diffuse left ventricle (LV) wall uptake …

Cardiac sarcoidosis (CS) is a rare and potentially life-threatening disease that causes
conduction disturbance, systolic dysfunction, and most notably sudden cardiac death. Accurate …

Study objective Although the overnight increase in urinary uric acid/creatinine ratio (ΔUA/Cr)
is considered by some to be a marker of tissue hypoxia in patients with obstructive sleep …

Increased oxidative stress has been associated with obesity-related disorders. In this study,
we investigated how oxidative stress, in different ways of exposure, regulates gene …